Scientists launch largest Real-World study of rare angiosarcoma
NCT ID NCT06375941
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study follows 250 people with localized angiosarcoma, a rare cancer of blood vessels. Researchers will collect information on tumor features, patient history, and standard treatments used in everyday practice. The goal is to better understand the disease and guide future care, but no new treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study succeeds, it could help doctors better understand angiosarcoma and improve future treatment guidelines.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data only, so it won't directly test or provide any new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOSARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O.U. Careggi
NOT_YET_RECRUITINGFlorence, 50134, Italy
-
AOU San Luigi Gonzaga
RECRUITINGOrbassano, Torino, 10043, Italy
-
ASL Ospedale San Giovanni Bosco
RECRUITINGTorino, 10154, Italy
-
Centro Riferimento Oncologico CRO
RECRUITINGAviano, Pordenone, 33081, Italy
-
Fondazione Irccs San Gerardo Dei Tintori
NOT_YET_RECRUITINGMonza, 20900, Italy
-
Fondazione Policlinico Campus Biomedico
RECRUITINGRoma, 00128, Italy
-
IOV Istituto Oncologico Veneto IRCCS
RECRUITINGPadova, 35128, Italy
-
IRCCS Istituti Fisioterapici Ospitalieri
NOT_YET_RECRUITINGRoma, 00144, Italy
-
IRCCS Istituto Europeo di Oncologia
NOT_YET_RECRUITINGMilan, 20141, Italy
-
IRCCS Istituto Nazionale Tumori - Milano
RECRUITINGMilan, 20133, Italy
-
Istituto Clinico Humanitas Research Hospital IRCCS
NOT_YET_RECRUITINGRozzano, Milano, 20089, Italy
-
Istituto Nazionale Tumori_Fondazione "G.Pascale"
RECRUITINGNaples, 80131, Italy
-
Istituto Ortopedico Rizzoli IOR
RECRUITINGBologna, 40136, Italy
-
Istituto Tumori "Giovanni Paolo II" I.R.C.C.S.
NOT_YET_RECRUITINGBari, 70124, Italy
-
Nuovo Ospedale di Prato - S. Stefano
RECRUITINGPrato, 59100, Italy
-
Ospedale Policlinico san Martino IRCCS
RECRUITINGGenova, 16132, Italy
-
Ospedale di Trento
NOT_YET_RECRUITINGTrento, 38123, Italy
-
Policlinico "Paolo Giaccone"
RECRUITINGPalermo, 90127, Italy
-
Policlinico "Sant'Orsola-Malpighi"
RECRUITINGBologna, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill may keep soft tissue sarcoma in check after chemo
- New combo therapy aims to shrink sarcomas
- New Two-Drug immune attack launched against tough cancers
- New cocktail aims to shrink sarcomas: bevacizumab joins chemo in phase 2 trial
- New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
- New hope for rare cancers? drug combo shows promise in early trial